Jeffrey E Mckinney, NP
Nurse Practitioner · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 15 years
- Graduated 2011
On the public record
- 2 Medical Board actions on record
Offices
2 locations · University of California San Francisco · Regents of the University of California
Hospitals listed: Mad River Community Hospital · Providence Queen of the Valley Medical Center · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jeffrey E Mckinney’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C21011 · Cancelled
Licence status: Cancelled · since 1959 · Temple University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 1991-08-29 | Board disciplineDiscipline | Effective 08/29/91 cannot practice medicine until passing an evaluation. ten years probation with various terms and conditions. · 13 1990005518 |
| 1988-07-14 | Action in another state or by a federal agencyDiscipline | Effective 7/14/88 emergency suspension issued. effective 9/16/88 probation for an indeterminate time. · Florida board of medicine |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mad River Community HospitalArcata, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Mad River Community Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 1 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.24 to 2.4) · 88 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.53 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.9 · 226 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 681 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 680 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.26 (1.7 to 6.82) · 164 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 155 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (0 to 18.78) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.02 (1.73 to 10.3) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.73) · 534 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 1.755 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 25 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.5 · 37 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.7 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.4 to 16.8) · 650 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 69 cases | No different | Jan 2024 – Dec 2024 |
What patients said (133 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 60% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$25,664
Medicare paid this office $25,664 for 162 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 103 | $14,559 | $105 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $2,817 | $66 |
| Long return visit (40+ min) | 13 | $2,307 | $121 |
| Return visit (30+ min) | 32 | $2,065 | $54 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 92 | $1,324 | $12 |
See all 7 services
| Long return visit (40+ min) | 103 | $14,559 | $105 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $2,817 | $66 |
| Long return visit (40+ min) | 13 | $2,307 | $121 |
| Return visit (30+ min) | 32 | $2,065 | $54 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 92 | $1,324 | $12 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 31 | $858 | $24 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $144 | $11 |
Who their Medicare patients are
162 Original Medicare patients in 2024. Average age 71 · Women 40% · Also on Medicaid 60% · Health risk score 2.24. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 43% · Chronic kidney disease 30% · Coronary heart disease 23% · Atrial fibrillation 21% · Depression 20% · Heart failure 19% · Cancer 17% · COPD 16%.
The office billed $180,661, Medicare allowed $34,759 and paid $25,664; for 423 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 162 | 423 | 71 | 2.24 | $180,661 | $25,664 |
| 2023 | 131 | 228 | 69 | 2.29 | $128,845 | $18,668 |
| 2022 | 156 | 297 | 71 | 2.19 | $179,848 | $25,778 |
| 2021 | 150 | 300 | 70 | 2.54 | $175,393 | $24,706 |
| 2020 | 148 | 281 | 70 | 2.67 | $158,747 | $19,216 |
| 2019 | 122 | 191 | 69 | 2.42 | $138,775 | $14,513 |
| 2018 | 96 | 132 | 67 | 2.21 | $92,708 | $10,009 |
| 2017 | 91 | 120 | 66 | 2.52 | $75,922 | $8,991 |
| 2014 | 109 | 235 | 67 | 1.56 | $45,260 | $12,920 |
| 2013 | 20 | 31 | 65 | 2.41 | $5,648 | $1,668 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 66 | $9,859 | $103 |
| Return visit (30+ min) | 37 | $3,158 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $2,663 | $62 |
| Long return visit (40+ min) | 11 | $1,382 | $126 |
| Short return visit (20+ min) | 12 | $499 | $38 |
2022: 5 services
| Long return visit (40+ min) | 94 | $16,217 | $106 |
| Return visit (30+ min) | 32 | $2,657 | $65 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $2,532 | $63 |
| Long return visit (40+ min) | 15 | $2,083 | $123 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $340 | $24 |
2021: 6 services
| Long return visit (40+ min) | 88 | $15,478 | $106 |
| Return visit (30+ min) | 45 | $3,424 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $1,990 | $64 |
| Short return visit (20+ min) | 12 | $518 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $518 | $47 |
| Measurement of liver stiffness | 12 | $78 | $6 |
2020: 6 services
| Long return visit (40+ min) | 92 | $11,515 | $79 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $2,679 | $60 |
| Long return visit (40+ min) | 14 | $1,498 | $88 |
| Return visit (30+ min) | 15 | $953 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $747 | $39 |
| Measurement of liver stiffness | 11 | $111 | $10 |
2019: 2 services
| Long return visit (40+ min) | 95 | $10,501 | $81 |
| Return visit (30+ min) | 24 | $1,487 | $55 |
2018: 2 services
| Long return visit (40+ min) | 72 | $6,755 | $79 |
| Return visit (30+ min) | 27 | $1,491 | $53 |
2017: 2 services
| Long return visit (40+ min) | 68 | $6,844 | $83 |
| Return visit (30+ min) | 29 | $1,974 | $60 |
2014: 3 services
| Return visit (30+ min) | 96 | $10,886 | $55 |
| Long return visit (40+ min) | 12 | $923 | $77 |
| Short return visit (20+ min) | 11 | $464 | $31 |
2013: 1 service
| Return visit (30+ min) | 17 | $1,438 | $55 |
Drugs they prescribed that Part D paid
$507,095
Pharmacies billed $507,095 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 242) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
126 generic and 116 brand-name prescriptions · $507,095 in drug cost · 51 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 43 | $130,476 | $3,034 |
| Vemlidy | 54 | $75,377 | $1,396 |
| Entecavir | 18 | $2,573 | $143 |
| Ursodiol | 16 | $1,029 | $64 |
| Furosemide | 19 | $79 | $4 |
See all 6 drugs
| Xifaxan | 43 | $130,476 | $3,034 |
| Vemlidy | 54 | $75,377 | $1,396 |
| Entecavir | 18 | $2,573 | $143 |
| Ursodiol | 16 | $1,029 | $64 |
| Furosemide | 19 | $79 | $4 |
| Carvedilol | 22 | $47 | $2 |
Year by year
| 2024 | 242 | 46 | 0% (0) | 48% | $507,095 |
| 2023 | 280 | 52 | None | 47% | $629,205 |
| 2022 | 204 | 47 | None | 39% | $493,552 |
| 2021 | 187 | 40 | 0% (0) | 49% | $986,245 |
| 2020 | 258 | 44 | 0% (0) | 47% | $1,333,139 |
| 2019 | 228 | 59 | 0% (0) | 47% | $1,533,472 |
| 2018 | 271 | 64 | None | 46% | $2,036,664 |
| 2017 | 375 | 60 | None | None | $2,443,026 |
| 2016 | 375 | 66 | 0% (0) | 50% | $3,393,321 |
| 2015 | 432 | 99 | None | 64% | $7,140,172 |
| 2014 | 519 | 97 | None | 67% | $7,238,603 |
| 2013 | 157 | 40 | 0% (0) | 47% | $78,300 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Epclusa | 12 | $326,429 | $27,202 |
| Xifaxan | 40 | $134,531 | $3,363 |
| Vemlidy | 69 | $103,920 | $1,506 |
| Entecavir | 12 | $5,996 | $500 |
| Ursodiol | 11 | $879 | $80 |
| Spironolactone | 24 | $253 | $11 |
| Furosemide | 19 | $118 | $6 |
2022: 6 drugs
| Epclusa | 12 | $320,675 | $26,723 |
| Xifaxan | 33 | $104,478 | $3,166 |
| Vemlidy | 19 | $26,196 | $1,379 |
| Entecavir | 17 | $10,024 | $590 |
| Spironolactone | 28 | $287 | $10 |
| Furosemide | 27 | $89 | $3 |
2021: 4 drugs
| Epclusa | 45 | $846,161 | $18,804 |
| Xifaxan | 24 | $68,745 | $2,864 |
| Spironolactone | 31 | $344 | $11 |
| Furosemide | 29 | $48 | $2 |
2020: 8 drugs
| Epclusa | 43 | $985,755 | $22,925 |
| Xifaxan | 26 | $68,406 | $2,631 |
| Vemlidy | 14 | $18,802 | $1,343 |
| Lactulose | 17 | $888 | $52 |
| Spironolactone | 32 | $363 | $11 |
| Propranolol | 13 | $202 | $16 |
| Ciprofloxacin | 13 | $182 | $14 |
| Furosemide | 32 | $97 | $3 |
2019: 6 drugs
| Epclusa | 28 | $708,835 | $25,316 |
| Harvoni | 11 | $355,542 | $32,322 |
| Xifaxan | 27 | $67,926 | $2,516 |
| Lactulose | 24 | $1,407 | $59 |
| Spironolactone | 29 | $406 | $14 |
| Furosemide | 32 | $108 | $3 |
2018: 11 drugs
| Harvoni | 26 | $813,921 | $31,305 |
| Epclusa | 26 | $634,991 | $24,423 |
| Vosevi | 14 | $339,713 | $24,265 |
| Mavyret | 11 | $145,170 | $13,197 |
| Xifaxan | 33 | $72,713 | $2,203 |
| Entecavir | 19 | $18,493 | $973 |
| Ribavirin | 18 | $4,592 | $255 |
| Lactulose | 22 | $788 | $36 |
| Spironolactone | 23 | $298 | $13 |
| Ciprofloxacin | 18 | $100 | $6 |
| Furosemide | 15 | $46 | $3 |
2017: 12 drugs
| Epclusa | 24 | $610,415 | $25,434 |
| Harvoni | 20 | $606,341 | $30,317 |
| Sovaldi | 14 | $396,688 | $28,335 |
| Zepatier | 16 | $290,616 | $18,163 |
| Xifaxan | 45 | $91,357 | $2,030 |
| Entecavir | 17 | $18,589 | $1,093 |
| Ribavirin | 31 | $6,683 | $216 |
| Propranolol | 22 | $290 | $13 |
| Spironolactone | 18 | $245 | $14 |
| Ciprofloxacin | 33 | $202 | $6 |
| Doxepin | 12 | $193 | $16 |
| Furosemide | 26 | $81 | $3 |
2016: 14 drugs
| Harvoni | 28 | $882,302 | $31,511 |
| Sovaldi | 31 | $872,056 | $28,131 |
| Epclusa | 22 | $557,725 | $25,351 |
| Daklinza | 24 | $508,251 | $21,177 |
| Zepatier | 18 | $330,095 | $18,339 |
| Xifaxan | 36 | $66,203 | $1,839 |
| Viread | 13 | $12,134 | $933 |
| Ribavirin | 32 | $5,401 | $169 |
| Ribasphere | 11 | $1,864 | $169 |
| Propranolol | 23 | $341 | $15 |
| Omeprazole | 30 | $253 | $8 |
| Spironolactone | 12 | $149 | $12 |
| Pantoprazole | 14 | $90 | $6 |
| Furosemide | 22 | $86 | $4 |
2015: 7 drugs
| Harvoni | 193 | $6,102,457 | $31,619 |
| Sovaldi | 26 | $682,972 | $26,268 |
| Xifaxan | 25 | $50,503 | $2,020 |
| Ribavirin | 40 | $7,759 | $194 |
| Omeprazole | 34 | $210 | $6 |
| Spironolactone | 13 | $207 | $16 |
| Furosemide | 21 | $117 | $6 |
2014: 10 drugs
| Sovaldi | 151 | $4,278,504 | $28,334 |
| Harvoni | 47 | $1,491,435 | $31,733 |
| Olysio | 57 | $1,279,127 | $22,441 |
| Pegasys Proclick | 28 | $87,237 | $3,116 |
| Xifaxan | 13 | $20,913 | $1,609 |
| Viread | 20 | $17,446 | $872 |
| Ribasphere | 57 | $9,023 | $158 |
| Ribavirin | 36 | $5,426 | $151 |
| Spironolactone | 21 | $377 | $18 |
| Prednisone | 12 | $57 | $5 |
2013: 4 drugs
| Baraclude | 17 | $25,458 | $1,498 |
| Xifaxan | 19 | $21,237 | $1,118 |
| Lactulose | 12 | $794 | $66 |
| Ursodiol | 13 | $582 | $45 |
Money from drug and device companies
$226 in 2023
| 2023 | 3 | 4 | None | $226 |
| 2022 | 2 | 3 | None | $119 |
| 2021 | 2 | 13 | $2,040 | $3,568 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $140 | 2 payments
|
| Abbvie | Mavyret | $73 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
See all 4 published payments
| Abbvie | Meals · 2023-06-12 | Mavyret | $73 |
| Boston Scientific | Meals · 2023-04-20 | Therasphere Y90 Glass Microspheres 10 Gbq | $125 |
| Boston Scientific | Meals · 2023-03-08 | Therasphere Y90 Glass Microspheres 10 Gbq | $15 |
| Gilead Sciences | Meals · 2023-02-21 | None | $13 |
See earlier years (2022, 2021)
2022: $119
| Abbvie | Mavyret | $95 | 2 payments
|
| Gilead Sciences | None | $23 | 1 payment
|
2021: $3,568
| Gilead Sciences | Epclusa | $3,512 | 12 payments
|
| AbbVie | Mavyret | $56 | 1 payment
|
Professional record
- NPI
- 1740553494
- Licence
- CA 21011California C21011: Cancelled
- Group
- University of California San Francisco · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 750 Welch Rd, Suite 215, Palo Alto, CA, 94304
- NPI first listed
- 2012-02-10
- NPI last updated
- 2014-07-22
This is when the NPI record was last certified, not a medical board exam.